ESN-C(Enveda Therapeutics)

N/A

Report date: 2024/12/03 15:47:27
NMEFirst In Class

Base Information

Drug NameESN-C(Enveda Therapeutics)
Drug Alias NameESN-C(Enveda Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMas-related G-protein coupled receptor member X4 antagonists
TargetsMas-related G-protein coupled receptor member X4
Therapy Area/IndicationsPruritus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesEnveda Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnveda Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPruritus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A